These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 15031527)
21. Inhibition of toll-like receptor 7- and 9-mediated alpha/beta interferon production in human plasmacytoid dendritic cells by respiratory syncytial virus and measles virus. Schlender J; Hornung V; Finke S; Günthner-Biller M; Marozin S; Brzózka K; Moghim S; Endres S; Hartmann G; Conzelmann KK J Virol; 2005 May; 79(9):5507-15. PubMed ID: 15827165 [TBL] [Abstract][Full Text] [Related]
22. Roles of toll-like receptors in natural interferon-producing cells as sensors in immune surveillance. Ito T; Amakawa R; Fukuhara S Hum Immunol; 2002 Dec; 63(12):1120-5. PubMed ID: 12480255 [TBL] [Abstract][Full Text] [Related]
23. Intracellular bacterial infection-induced IFN-gamma is critically but not solely dependent on Toll-like receptor 4-myeloid differentiation factor 88-IFN-alpha beta-STAT1 signaling. Rothfuchs AG; Trumstedt C; Wigzell H; Rottenberg ME J Immunol; 2004 May; 172(10):6345-53. PubMed ID: 15128825 [TBL] [Abstract][Full Text] [Related]
24. Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence. Stack J; Haga IR; Schröder M; Bartlett NW; Maloney G; Reading PC; Fitzgerald KA; Smith GL; Bowie AG J Exp Med; 2005 Mar; 201(6):1007-18. PubMed ID: 15767367 [TBL] [Abstract][Full Text] [Related]
25. Toll-like receptor 3-mediated activation of NF-kappaB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-beta. Jiang Z; Mak TW; Sen G; Li X Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3533-8. PubMed ID: 14982987 [TBL] [Abstract][Full Text] [Related]
26. Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3. Kulka M; Alexopoulou L; Flavell RA; Metcalfe DD J Allergy Clin Immunol; 2004 Jul; 114(1):174-82. PubMed ID: 15241362 [TBL] [Abstract][Full Text] [Related]
27. Subcellular localization of Toll-like receptor 3 in human dendritic cells. Matsumoto M; Funami K; Tanabe M; Oshiumi H; Shingai M; Seto Y; Yamamoto A; Seya T J Immunol; 2003 Sep; 171(6):3154-62. PubMed ID: 12960343 [TBL] [Abstract][Full Text] [Related]
32. Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex. Youn HS; Lee JY; Fitzgerald KA; Young HA; Akira S; Hwang DH J Immunol; 2005 Sep; 175(5):3339-46. PubMed ID: 16116226 [TBL] [Abstract][Full Text] [Related]
33. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Li K; Foy E; Ferreon JC; Nakamura M; Ferreon AC; Ikeda M; Ray SC; Gale M; Lemon SM Proc Natl Acad Sci U S A; 2005 Feb; 102(8):2992-7. PubMed ID: 15710891 [TBL] [Abstract][Full Text] [Related]
34. Analysis of genes induced by Sendai virus infection of mutant cell lines reveals essential roles of interferon regulatory factor 3, NF-kappaB, and interferon but not toll-like receptor 3. Elco CP; Guenther JM; Williams BR; Sen GC J Virol; 2005 Apr; 79(7):3920-9. PubMed ID: 15767394 [TBL] [Abstract][Full Text] [Related]
35. The clathrin-mediated endocytic pathway participates in dsRNA-induced IFN-beta production. Itoh K; Watanabe A; Funami K; Seya T; Matsumoto M J Immunol; 2008 Oct; 181(8):5522-9. PubMed ID: 18832709 [TBL] [Abstract][Full Text] [Related]
36. Nuclear factor κB subunits RelB and cRel negatively regulate Toll-like receptor 3-mediated β-interferon production via induction of transcriptional repressor protein YY1. Siednienko J; Maratha A; Yang S; Mitkiewicz M; Miggin SM; Moynagh PN J Biol Chem; 2011 Dec; 286(52):44750-63. PubMed ID: 22065573 [TBL] [Abstract][Full Text] [Related]
37. Cutting Edge: NF-kappaB-activating kinase-associated protein 1 participates in TLR3/Toll-IL-1 homology domain-containing adapter molecule-1-mediated IFN regulatory factor 3 activation. Sasai M; Oshiumi H; Matsumoto M; Inoue N; Fujita F; Nakanishi M; Seya T J Immunol; 2005 Jan; 174(1):27-30. PubMed ID: 15611223 [TBL] [Abstract][Full Text] [Related]